Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
13F holders, Q4 2021
Institutional positions in Evotec SE as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +20 vs. Q3 2021
- Shares held
- 6.62M
- +6.62M vs. Q3 2021
- Total value
- $157.3M
- +$157.3M vs. Q3 2021
- New holders
- 20
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $9.07M |
| Q1 2026 | 46 | $20.3M |
| Q4 2025 | 44 | $30.4M |
| Q3 2025 | 37 | $35.9M |
| Q2 2025 | 37 | $40.5M |
| Q1 2025 | 25 | $30.4M |
| Q4 2024 | 26 | $36.9M |
| Q3 2024 | 24 | $29.6M |
| Q2 2024 | 28 | $35.0M |
| Q1 2024 | 20 | $38.7M |
| Q4 2023 | 28 | $66.5M |
| Q3 2023 | 24 | $12.0M |
| Q2 2023 | 20 | $15.4M |
| Q1 2023 | 19 | $14.5M |
| Q4 2022 | 22 | $21.1M |
| Q3 2022 | 22 | $43.5M |
| Q2 2022 | 21 | $57.3M |
| Q1 2022 | 22 | $83.3M |
| Q4 2021 | 20 | $157.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Evotec SE; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artisan Partners Limited Partnership | 2,234,623 | $53.1M | 0.06% | +2,234,623 | New |
| Franklin Resources Inc | 1,501,879 | $35.7M | 0.01% | +1,501,879 | New |
| Artal Group S.A. | 1,149,425 | $27.3M | 0.80% | +1,149,425 | New |
| Federated Hermes, Inc. | 689,655 | $16.4M | 0.03% | +689,655 | New |
| Millennium Management LLC | 451,466 | $10.7M | 0.01% | +451,466 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 300,288 | $7.13M | 0.03% | +300,288 | New |
| Caas Capital Management LP | 127,903 | $3.04M | 0.28% | +127,903 | New |
| Jane Street Group, LLC | 56,682 | $1.37M | 0.00% | +56,682 | New |
| Morgan Stanley | 34,388 | $816.0K | 0.00% | +34,388 | New |
| Price T Rowe Associates Inc | 22,188 | $527.0K | 0.00% | +22,188 | New |
| Marshall Wace, LLP | 16,272 | $387.0K | 0.00% | +16,272 | New |
| Point72 Hong Kong Ltd | 13,843 | $329.0K | 0.03% | +13,843 | New |
| Geode Capital Management, LLC | 12,785 | $303.0K | 0.00% | +12,785 | New |
| Bank of America Corp | 6,634 | $158.0K | 0.00% | +6,634 | New |
| UBS Group AG | 1,991 | $47.0K | 0.00% | +1,991 | New |
| Wells Fargo & Company | 1,002 | $24.0K | 0.00% | +1,002 | New |
| Reilly Financial Advisors, LLC | 420 | $10.0K | 0.00% | +420 | New |
| Tower Research Capital LLC (TRC) | 130 | $3.00K | 0.00% | +130 | New |
| Cubist Systematic Strategies, LLC | 62 | $1.00K | 0.00% | +62 | New |
| Bell Investment Advisors, Inc | 22 | $1.00K | 0.00% | +22 | New |